The molecular mechanisms underlying the interdependence between intracellular trafficking and epithelial cell polarity are poorly understood. Here we show that inactivation of class III phosphatidylinositol-3-OH kinase (CIII-PI3K), which produces phosphatidylinositol-3-phosphate (PtdIns3P) on endosomes, disrupts epithelial organization. This is caused by dysregulation of endosomally localized Liver Kinase B1 (LKB1, also known as STK11), which shows delocalized and increased activity accompanied by dysplasia-like growth and invasive behaviour of cells provoked by JNK pathway activation. CIII-PI3K inactivation cooperates with Ras V12 to promote tumour growth in vivo in an LKB1-dependent manner. Strikingly, co-depletion of LKB1 reverts these phenotypes and restores epithelial integrity. The endosomal, but not autophagic, function of CIII-PI3K controls polarity. We identify the CIII-PI3K effector, WD repeat and FYVE domain-containing 2 (WDFY2), as an LKB1 regulator in Drosophila tissues and human organoids. Thus, we define a CIII-PI3K-regulated endosomal signalling platform from which LKB1 directs epithelial polarity, the dysregulation of which endows LKB1 with tumour-promoting properties.
Loss of epithelial cell polarity is frequently coupled to excess cell proliferation and tissue growth. Work in model organisms revealed that epithelial polarity module components and endosomal transport regulators act interdependently to ensure epithelial polarization, integrity and regulated cell proliferation, leading to their co-classification as neoplastic tumour-suppressor genes 1 . The underlying mechanisms for this interdependence remain elusive.
LKB1 haplo-insufficiency is responsible for the cancerpredisposing Peutz-Jeghers syndrome 2 . The realization that LKB1 phosphorylates and activates the cellular energy-sensing AMP kinase (AMPK) that in turn negatively regulates Target of Rapamycin Complex1 (TORC1), contributed to the mechanistic understanding and classification of LKB1 and AMPK as tumour suppressors 3 . LKB1 and AMPK play multiple roles during cell polarization in Caenorhabditis elegans, Drosophila and mammalian cell culture systems [4] [5] [6] [7] . In vivo studies have demonstrated that lipid modification of AMPK (myristoylation) and LKB1 (prenylation) is essential for membrane association, effective AMPK phosphorylation and oocyte polarization 7, 8 . Recent work suggests that LKB1-AMPK regulation of TORC1 occurs on the exterior of the RAB7/LAMP1-positive lysosomal membrane 9, 10 . Together, these findings argue that membranes provide an important signalling platform for LKB1.
The lipid kinase CIII-PI3K has three core subunits; VPS34 kinase (or PIK3C3), and the regulatory subunits VPS15 and the tumour suppressor Beclin-1. It comes in two versions, defined by the presence of ATG14 or UVRAG that regulates macroautophagy (autophagy, hereafter) or endocytosis, respectively ( Fig. 1a-a ) . Localized PtdIns3P production on membranes recruits proteins containing PX or FYVE domains. These effector proteins (at least 70 in human) often contain additional protein-protein interaction domains that exert CIII-PI3K-dependent effects 11 . Endosomal CIII-PI3K is recruited to early endosomes via association with RAB5 where it is important for the maturation of the vesicle to the RAB7-positive endosome 12, 13 . Herein, we show that inactivation of CIII-PI3K causes dysregulation of LKB1 endosomal trafficking and signalling activity, leading to alteration of cell polarity and disruption of epithelial architecture both in vivo and in human organoids. We identify a conserved role of the endosomal PtdIns3P effector WDFY2 as an essential LKB1-regulating protein. Endocytic Lkb1 dysregulation appears relevant to tumour growth, as loss of CIII-PI3K cooperates with Ras V12 to promote tumorigenesis in an Lkb1-dependent manner in vivo. (f) Caco-2 cells cultured in Matrigel in the absence or presence of the CIII-PI3K inhibitors 3-methyladenine (3-MA) and SAR405, labelled with anti-actin, aPKC and Hoechst (DNA). Scale bars, 10 µm. (g) Penetrance (%) of multi-lumen phenotypes in control (media swap or DMSO) and treated (3-MA or SAR405) Caco-2 cysts sub-grouped into phenotypes 1, 2 or more than 2 lumens. Chi-square test P values comparing with controls were <0.00001 (3-MA) and 0.019 (SAR405). n represents the total number of cysts; n values are indicated in the graph. (h) Caco-2 cells transfected with siRNA control (si-Ctrl) or knocking down the CIII-PI3K components Beclin-1 (si-BECN1), VPS34 (si-VPS34) and ATG14 (si-ATG14) prior to culturing in Matrigel and labelling with anti-aPKC and Hoechst (DNA). Scale bars, 10 µm. (i) Caco-2 cells transfected with the indicated siRNA were scored for multi-lumen phenotypes similarly to g. Chi-square test P values comparing with si-Ctrl were <0.00001 (si-BECN1), 0.00006 (si-VPS34) and 0.36 (si-ATG14). n represents the total number of cysts. n values are indicated in the graph. siRNA knockdown efficiency is assessed in Supplementary  Fig. 7 . For all panels, three independent experiments were performed with similar results.
RESULTS

CIII-PI3K is required for Drosophila and human epithelial organization
To uncover potential functions of CIII-PI3K in epithelia, we generated loss-of-function clones of the core components Vps15 and Vps34 in the follicular epithelial (FE) cell layer of the developing egg chamber (Fig. 1b) . Loss of either vps15 or vps34 gave rise to dysplasialike alterations characterized by epithelial multilayering, intracellular retention and increased levels of the adherence junction markers Armadillo (Arm) and E-cadherin (E-Cad), as well as occasional overlap between apical (aPKC) and basolateral (Discs large, Dlg) markers (Fig. 1c-e and Supplementary Fig. 1a,b) . This is in line with earlier observations 14, 15 . Epithelial disruption could be rescued by expression of a vps34 transgene within vps34 −/− cells using the mosaic analysis with a repressible cell marker (MARCM) technique 16 ( Fig. 1e and Supplementary Fig. 1c,d ). In contrast to vps34 −/− and vps15 −/− , large atg14 −/− clones never showed disruption of epithelial organization or perturbation of cell polarity ( Fig. 1e and Supplementary Fig. 1e ), ruling out a contribution of the autophagic function of CIII-PI3K to this phenotype.
To investigate conservation of this epithelial function, we turned to human organoids. Cultured in Matrigel, Caco-2 cells form organoid structures composed of monolayered polarized epithelial cysts in which the apical surface of cells faces a liquid-filled lumen (Fig. 1f) 17 . Pharmacological inactivation of VPS34, using 3-methyladenine (3-MA) or SAR405 (ref. 18) , increased the proportion of cysts with multiple lumens, suggesting that CIII-PI3K is required for regulated epithelial polarization in this system (Fig. 1f,g ). Knockdown of CIII-PI3K core complex components, VPS34 and BECN1, gave rise to multi-lumen cysts, while knockdown of ATG14 had no effect (Fig. 1h,i) . We conclude that the endosomal, not autophagic, function of CIII-PI3K plays a conserved role in epithelial organization.
CIII-PI3K-mediated restriction of LKB1 activity is required for epithelial organization
Drosophila CIII-PI3K mutant FE cells displayed opposite phenotypes to those reported for lkb1 −/− (ref. 7) ( Supplementary Fig. 2a ), leading us to examine Lkb1 localization in CIII-PI3K mutant clones. Both endogenous Lkb1 and ubiquitously expressed GFP-tagged Lkb1 were enriched at the plasma membrane of control cells, whereas in vps34
−/− cells, Lkb1 levels were increased, both at the plasma membrane and the cytosol (Fig. 2a,b and Supplementary Fig. 2c,d) .
We next asked whether increased Lkb1 levels translate into higher activity. Immunolabelling of the Lkb1 phosphorylation target site of AMPK (p-AMPK) localized close to basolateral membranes in wild-type FE cells and was strongly decreased in lkb1 −/− clones ( Supplementary Fig. 2b) , showing that Lkb1 is the major kinase regulating AMPK activity in this tissue. In CIII-PI3K mutant cells, the p-AMPK signal was increased and redistributed from predominantly lateral membrane to a dispersed lateral and cytoplasmic signal in vps34 −/− cells (Fig. 2c ). VPS34 knockdown, or pharmacological inhibition of VPS34 in confluent Caco-2 cells by SAR405, increased the ratio of p-AMPK to total AMPK (Fig. 2d-f and Supplementary Fig. 2e ), phenocopying the observations in vivo and suggesting a conserved function of CIII-PI3K in LKB1 activity regulation.
AMPK activation appears not to be a secondary effect of loss of autophagy or polarity, as autophagy-deficient (atg14 −/− ) or polaritydeficient (crumbs (crb), lethal giant larvae (lgl)) cells displayed no detectable accumulation of p-AMPK ( Supplementary Fig. 2f-h ).
To address whether ectopic LKB1 activity is causal to epithelial disruption, we analysed vps15 −/− lkb1 −/− double-mutant cells and vps34 −/− mutant cells in which lkb1 was silenced by RNA-mediated interference (RNAi; Fig. 2g ,h and Supplementary Fig. 2i,j) . Strikingly, in both situations, epithelial multilayering and elevated levels and mislocalization of Arm, E-Cad and p-AMPK were rectified to levels similar to lkb1 −/− alone. LKB1 depletion had no marked effect on three-dimensional (3D)-cultured Caco-2 cell epithelial polarity and/or lumen formation, distinct from earlier findings in confluent Caco-2 culture 6 ( Fig. 2i,j) . This may result from incomplete knockdown or differences between 2D and 3D culture conditions. Importantly, co-depletion of LKB1 restored the normal lumen formation frequency in VPS34-depleted cysts to control levels (Fig. 2i,j) . Together, these results suggest that LKB1 activity in response to VPS34 inactivation is responsible for the epithelial disruption phenotypes, placing the LKB1 functionally downstream of CIII-PI3K in both flies and humans.
LKB1 associates with endosomes and is regulated by endocytic trafficking
To investigate whether LKB1 signalling is indeed regulated by endocytic trafficking, we first employed the epithelium of Drosophila wing imaginal disc, which is well suited for genetic interaction analysis (Fig. 3a) . Inactivation of CIII-PI3K in the dorsal compartment of the wing, using ap-GAL4-driven expression of dominant-negative vps34 (vps34 DN ) or knockdown of vps34 or vps15, produced increased p-AMPK levels in the dorsal compartment, accompanied by a strong upward bending of the adult wing (Fig. 3b,c and Supplementary Fig. 3a) . Importantly, the vps34 DN wing bending was suppressed by lkb1 knockdown, validating this system for functional analysis (Fig. 3c-e) .
We uncovered genetic interaction between vps34 DN and both Rab5 and Rab7, early and late endosomal small GTPases respectively. While neither wild-type Rab5 nor constitutively active Rab7 (Rab7 CA ) affected wing morphology, both enhanced the vps34 DN phenotype (Fig. 3f-i) . Knockdown of vps34 caused increased labelling of Rab7, suggesting that the apically positioned Rab7 compartment size is enlarged (Supplementary Fig. 3b ). Co-expression of the early endosomal Rab5 (GFP::Rab5) indicated that knockdown of vps34 increased the overlap between the Rab5 and Rab7 compartments ( Supplementary Fig. 3c,d ), in line with the proposed role of CIII-PI3K in RAB5 to RAB7 endosomal maturation 12, 13 . Reasoning that Lkb1 signalling may occur from endosomes, we examined Lkb1 and AMPK localization and activity relative to endosomal compartments. GFP-tagged Lkb1 partially co-localized with Rab7 and, to a lesser extent, with Rab5 close to intercellular junctions in FE cells (Fig. 3j,k) . Cherry-tagged AMPKα and immunolabelling of its activated form p-AMPK both localized to Rab7 compartments, suggesting that Lkb1 is active and signalling from endosomes ( Supplementary Fig. 3e,f) . Next we employed Caco-2 cells expressing GFP-tagged LKB1 with mCherry-tagged RAB5 or RAB7. In the process of polarizing, sub-confluent Caco-2 cells displayed a subset of mobile structures double positive for LKB1 and either RAB5 or RAB7 Using live imaging to investigate the effect of acute inhibition of CIII-PI3K on endosomal LKB1 positioning, we observed a significant reduction in the number of LKB1/RAB7 double-positive vesicles following SAR405 treatment compared with pre-treatment and parallel control from the earliest time points onwards ( Supplementary Fig. 4d ), indicating that the presence of LKB1 on Rab5 vesicles was independent of VPS34. We noted the appearance of newly formed GFP-tagged LKB1 punctae following the addition of SAR405 (Fig. 4c,e) , many of which were RAB5 positive (arrowheads in Fig. 4e and Supplementary Video 4). Asking whether these punctae represented recently formed functional endosomes, we assessed accessibility by the endocytic cargo Alexa-647 Transferrin. Stable RAB5/LKB1-expressing cells were imaged in the presence of SAR405 pre-and post-incubation with labelled Transferrin. The observation of triple-positive vesicles (of large and small nature) suggests that emerging LKB1 punctae indeed were endocytic in identity and functionally accessible ( Supplementary Fig. 4e ).
The GTP-locked form of Rab5 (Rab5 CA ) and dominant-negative form of Rab7 perturb maturation of the early endosome 19, 20 , genetically mimicking SAR405 effects. Expression of Rab5 CA in the wing epithelium caused a marked increase in p-AMPK levels compared with neighbouring control cells, mainly localized to a subset of Rab5 CA vesicles ( Supplementary Fig. 3g ). Super-resolution microscopy placed the p-AMPK signal within a subset of these enlarged vesicles, presumably internalized ( Supplementary Fig. 3h ), implying that normal rates of endosomal maturation are required for appropriate p-AMPK levels. Similarly Rab7 DN expression in the wing epithelium caused striking accumulation of endogenous Lkb1 and increased p-AMPK levels, phenocopying CIII-PI3K loss (Fig. 4g) .
Thus, a fraction of LKB1 is associated with RAB5 and RAB7 endosomes in flies and human cells. We conclude that LKB1 passes from the RAB5 to the RAB7 compartment, and that interruption of regular endosomal maturation following CIII-PI3K inactivation leads to increased LKB1 signalling levels, contributing to epithelial disruption.
Identification of WDFY2, an endosomal PtdIns3P effector regulating LKB1
To identify potential LKB1-regulating PtdIns3P effectors, we devised a targeted genetic screen (Fig. 5a ). Of the 28 Drosophila PX-or FYVE-domain-encoding genes, 24 were screened by RNAimediated knockdown using available RNAi lines and the ap-GAL4 wing-bending assay, scoring for both wing bending that phenocopies vps34 DN and genetic interaction with vps34 DN . Positive hits were then scored for p-AMPK increases in vivo (Fig. 5b,c and Supplementary Table 1 ). The protein conservation between fly and human candidates was examined and relevant effectors were subsequently examined in the Caco-2 cyst formation assay. Strong positive hits in both systems included; Drosophila Blue Cheese (mammalian ALFY), a regulator of aggregate-induced autophagy 21 , Drosophila SH3PX1, homologous to the endosomal regulators SNX9,-18 and -33, and Drosophila CG5168, corresponding to human WDFY2 (referred to Chi-square test P values comparing with si-Ctrl were <0.00001 for all knockdown treatments. n represents the total number of cysts; n values are indicated in the graph. (f) Protein domain schematic of human WDFY2 (400 amino acids) indicating the site of the Arg315 to alanine (RA) FYVE-domain-breaking mutation. siRNA knockdown efficiency is assessed in Supplementary Fig. 7 . (g) Rescue of si-WDFY2-induced multi-lumen cysts was facilitated by expression of siRNA-resistant (siRes) GFP-tagged WDFY2 but not by expression of an siRNA-resistant GFP-tagged WDFY2 RA transgene, which disrupted cyst formation even in the presence of control siRNA. Scale bars, 5 µm. (h) Penetrance (percentage of total) of double-lumen phenotypes in control non-transfected (Caco-2) or WDFY2 siRNA-resistantor WDFY2
RA siRNA-resistant-expressing cell cysts treated with control siRNA or WDFY2 siRNA. Error bars represent s.d. P values calculated using the unpaired two-tailed Student's t-test. n = total number cysts; n values are indicated in the graph. All experiments were performed three times with similar results. as WDFY2 hereafter), an endosomal protein and recently identified carcinoma marker 22, 23 ( Fig. 5b-e) . As WDFY2 was reported to localize to early endosomes, several independent RNAi lines gave strong wing bending phenotypes with robust p-AMPK activation (Fig. 5c ) and knockdown of human WDFY2 gave penetrant lumen formation defects (Fig. 5d,e) , it represented a strong candidate LKB1 regulator. WDFY2 possesses seven WD40 repeats, shown to play a scaffolding role in AKT1 signalling 22 and a FYVE domain that targets PtdIns3P-positive membranes (Fig. 5f ) 20, 24 . Controlling for the specificity of the short interfering RNA (siRNA) phenotype, we performed knockdown of WDFY2 in wild-type Caco-2 cells or cells stably expressing siRNA-resistant GFP-tagged WDFY2 and observed that WDFY2 localized to apical endosomes in cysts and rescued the multi-lumen defects (Fig. 5g,h ). Rescue depended on an intact FYVE domain of WDFY2, as Caco-2 cells stably expressing an siRNA-resistant GFP-tagged WDFY2
RA mutant unable to bind PtdIns3P lost vesicular localization and failed to rescue multi-lumen defects ( Fig. 5f-h and Supplementary Fig. 6b,c) . Unexpectedly, this variant had penetrant lumen disruption phenotypes, suggesting that it had a dominant-negative effect (Fig. 5g,h ).
Endosomal WDFY2 regulates LKB1 to control epithelial integrity Co-expression of mCherry-tagged WDFY2 and the PtdIns3P reporter 2×FYVE-GFP that localizes to Rab5 and Rab7 endosomes 25 overlapped in a subset of structures in the FE (Supplementary Fig. 6a ). Mosaic genetic analysis revealed that the endosomal localization of WDFY2 depended on CIII-PI3K-generated PtdIns3P, as vps15 −/− cells displayed dispersed WDFY2 (Fig. 6a) . FYVE domain mutant WDFY2
RA was also cytoplasmically dispersed in both fly and Caco-2 cells (Fig. 6b and Supplementary Fig. 6b,c) . Live imaging of stable Caco-2 cell lines co-expressing GFP-tagged LKB1 and mCherrytagged WDFY2 revealed that they partially co-localize on motile vesicular structures (Fig. 6c and Supplementary Fig. 6d and Supplementary Video 5). Immunoprecipitation of LKB1 co-precipitated GFPtagged WDFY2 but not GFP alone from stably expressing Caco-2 cells, indicative of both proteins residing in a complex or on the same subcellular compartment (Fig. 6d) . Similarly, immunoprecipitation of GFP-tagged LKB1 co-precipitated mCherry-tagged WDFY2, but not mCherry alone, from stably expressing Caco-2 cells (Fig. 6e) . In vitro-translated fly Lkb1 and human LKB1 could be pulled down by bacterially expressed GST-tagged WDFY2 from both species (Supplementary Fig. 6e ). In this assay, binding was not affected by mutation in the FYVE domain. Together, these data suggest that WDFY2 and LKB1 exist in a molecular complex on endosomes.
We next sought to determine whether LKB1 was indeed regulated by WDFY2. Clonal expression of mCherry-tagged WDFY2 RA failed to localize to endosomal structures and led to an increase of p-AMPK levels in comparison with neighbouring FE cells (Fig. 6b) . To clarify whether WDFY2
RA had a dominant-negative effect due to the lack of PtdIns3P binding, we compared effects of pharmacological inhibition of VPS34 in WDFY2-or WDFY2 RAexpressing Caco-2 cells. Treatment with SAR405 led to an increased p-AMPK/AMPK ratio in WDFY2-expressing cells, as expected ( Fig. 6f and Supplementary Fig. 6f ). We noted that untreated WDFY2 RAexpressing cells had a higher basal p-AMPK/AMPK ratio than either WDFY2-expressing or control parental Caco-2 cell lines, the mislocalization of WDFY RA presumably mimicking the effect of VPS34 inhibition (Fig. 6f,g ). Consistent with the notion that WDFY2
RA acts dominant negatively, SAR405 treatment did not further increase the p-AMPK/AMPK ratio ( Fig. 6f and Supplementary  Fig. 6f ). Thus, inactivation or mislocalization of WDFY2 specifically due to lack of PtdIns3P or its binding ability leads to increased LKB1 activity, arguing that the activity of LKB1 may be responsible for WDFY2-related lumen formation defects.
To test the epistatic relationship between WDFY2 and Lkb1, we again turned to the wing. Overexpression of lkb1 or wdfy2 RA or knockdown of wdfy2 each phenocopied the Vps34 DN and vps34
RNAi upward wing bending (Fig. 6h-j) . Knockdown of lkb1 reversed wdfy2 RNAi -and wdfy2 RA -induced wing bending, demonstrating that it resulted from increased Lkb1 activity and suggesting that WDFY2 can regulate Lkb1 signalling in vivo (Fig. 6h-j) . This relationship is conserved in human cells, as the WDFY2 knockdown or WDFY2 RA lumen formation defects were suppressed by LKB1 co-depletion, placing LKB1 downstream of WDFY2 in the control of epithelial integrity (Fig. 7a-c and Supplementary Fig. 6g) .
Reasoning that the WDFY2 RA -expressing Caco-2 cell line represented a bona fide dominant-negative approach to study endosomal regulation of LKB1 activity and function, we performed co-culture experiments, mixing GFP-tagged WDFY2
RA -expressing cells with the GFP-negative parental Caco-2 cell line, recreating the Drosophila mosaic scenario. WDFY2
RA -expressing cells grew faster than control cells, and appeared to grow on top of each other in clumps, making disorganized, taller and more compact layers, best seen in X -Z cross-sections (Fig. 7d-f ). aPKC and E-cadherin immunolabelling revealed cytoplasmic retention and strong increases in levels of both markers compared with the neighbouring control cells, strikingly similar to defects of vps15 and vps34 mosaic tissues (Fig. 1c,d, Supplementary Fig. 1a,b and Fig. 7d-f ). In summary, we have identified WDFY2 as a conserved endosomal effector of CIII-PI3K, which physically interacts in a complex with LKB1 and controls its activity to maintain epithelial integrity. Moreover, loss of either CIII-PI3K or the PtdIns3P-binding activity of WDFY2 leads to dysplasia-like growth, enacted through increased LKB1 activity, raising the possibility that LKB1 may harbour tumourpromoting activity.
Cooperative tumour growth between Ras
V12 and CIII-PI3K depends on Lkb1 To determine whether CIII-PI3K inactivation promoted tumorigenesis through Lkb1 mis-regulation alone or in combination with an oncogene, we made MARCM vps34 −/− clones in early-stage egg chambers (stage 3-6), which revealed occasional invasion of GFP-positive vps34 −/− FE cells in amongst the germ cells (Fig. 8a) .
The Jun amino (N)-terminal Kinase (JNK) pathway is known to be regulated by Lkb1 in Drosophila
26
, and JNK is required for invasiveness of tumours through transcriptional activation of matrix metalloproteinase 1, (Mmp1; ref.
27). Analysis of vps34
−/− mosaic FE revealed increased Mmp1 levels within vps34 −/− clones that was reversed following lkb1 knockdown, suggesting that Lkb1 is upstream of JNK signalling and Mmp1 expression (Fig. 8a-c) . To address this, we generated vps34 −/− MARCM clones expressing dominantnegative Drosophila JNK, Basket (Bsk DN ). vps34 −/− ,bsk DN clones displayed normalized morphology and reduced Mmp1 expression compared with neighbouring cells (Fig. 8d,e) . These experiments place LKB1 upstream of JNK activation, and suggest that unrestrained LKB1 activity accounts for the epithelial disruption following loss of CIII-PI3K, in part through JNK signalling.
Previous work has shown that stress-activated JNK signalling contributes to epithelial disruption and tumour growth in several Ras V12 -driven tumour models 28, 29 . Typically, Ras V12 and JNK activation leads to neoplastic tumour growth, causing prolonged larval phase with delayed pupation. Resembling the results in the FE, clonal loss of CIII-PI3K in the eye-antennal disc led to epithelial disruption, JNK stress signalling and expression of Mmp1 in an Lkb1-dependent manner, but did not by itself cause compelling tumour growth or invasion (Fig. 8f-i) . We therefore asked whether inactivation of CIII-PI3K could cooperate with Ras V12 in tumour growth. As previously reported 28, 29 , clonal overexpression of Ras V12 alone caused moderate overgrowth in eye-antennal discs without delaying pupal formation (Fig. 8j,k) . Interestingly, simultaneous inactivation of CIII-PI3K in Ras V12 clones led to delayed pupation and a striking enhancement of tumour growth (Fig. 8j,m) . Importantly, both the delayed pupation and tumour overgrowth could be reversed by simultaneous removal of lkb1 (Fig. 8j,n) , which alone, or in combination with Ras V12 , showed no defect in either assay (Fig. 8g,j,l) . Thus, CIII-PI3K acts as a cooperative tumour suppressor with Ras V12 in an Lkb1-dependent manner, demonstrating that Lkb1 harbours contextual tumour-promoting properties in vivo.
DISCUSSION
We have demonstrated that the endosomal transport functions of CIII-PI3K and its downstream effector WDFY2 are required for attenuation of the cell-polarizing capacity of LKB1. We propose that the polarizing capacity of LKB1 occurs from an early endosomal compartment and that this capacity is blunted on late endosomes (Supplementary Fig. 7 ). Consistent with this hypothesis, we observed altered LKB1 signalling when affecting CIII-PI3K/WDFY2/RAB7. WDFY2 co-localizes with LKB1 and in vitro assays detect interaction between the proteins, although this may be indirect. More detailed analysis of WDFY2 function is required to resolve the mechanism by which WDFY2 controls LKB1 activity. WDFY2 has recently been identified as a marker for ovarian carcinoma 23 and our findings make assessment of the activation status of the LKB1 pathway in WDFY2-driven cancers [30] [31] [32] of interest. Downstream of CIII-PI3K loss and WDFY2 RA , dysregulated LKB1 activity promotes dysplasia-like growth, and elicits invasive behaviour in vivo. Increasing evidence supports the concept that LKB1 and AMPK may promote tumorigenesis under certain conditions, leading to their categorization as contextual oncogenes, postulated to act by preventing oxidative stress and maintaining metabolic homeostasis within oncogene-expressing cancer cells, in line with known roles of AMPK [33] [34] [35] . Our in vivo findings support and strengthen this hypothesis. Given the dual role of LKB1 in cell polarity and metabolism regulation, we put forth the concept that the activation of signalling pathways regulating cell polarity and epithelial integrity could cooperate or synergize with metabolic dependence on LKB1 signalling to promote tumour development.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of this paper. RNAi (vdrc 34166, vdrc 04494) were from VDRC (stock numbers indicated). The atg14 d5.2 allele was generated by imprecise excision of a P-element (EY14568) inserted in the 5 UTR of the atg14 gene 37 . pOT2-wdfy2 (LD41958/CG5168) was used as a template to generate pENTR-wdfy2 and QuickChange site-directed mutagenesis was used to generate pENTR-mCherry::wdfy2 R323A . Gateway cloning was performed to pPGW and pPW, resulting in pUAS-GFP::wdfy2 and pUAS-Ch::wdfy2 R323A , respectively, followed by embryonic injection (performed by Bestgene). Vials containing hs-flp flies were immersed in a 37 • C water bath to induce heat-shock for 75 min for loss-of-function clones. A gap of six days between heat shock and harvest of ovaries ensured that analysed clones were stem-cell-derived and large (>20 cells) in nature. act >CD2>GAL4 'flp-out' clones were heat-shocked for 20-60 min and analysed four to six days afterwards. For pupation rates, crosses were flipped daily and pupae of the correct genotype were counted from day 5 after egg laying (AEL) until day 11 AEL. Pupation rate was calculated by dividing the number of pupae on a given day by the total number of pupae at day 11 AEL. Vials containing more than 20 and fewer than 60 animals of the correct genotype were included in the analysis. Figure 8g : y,w, ey-flp/+; act>y + >GAL4, UAS-GFP/+; FRT82B, tub-GAL80/FRT82B, lkb1 X 5 . Figure 8h : y,w, ey-flp/+; act>y + >GAL4, UAS-GFP/+; FRT82B, tub-GAL80/FRT82B, vps15 ird1−5 . Figure 8i : y,w, ey-flp/+; act>y + >GAL4, UAS-GFP/+; FRT82B, tub-GAL80/FRT82B, vps15 ird1−5 , lkb1 X 5 . Figure 8j ,k: y,w, ey-flp/+; act>y + >GAL4, UAS-GFP/UAS-Ras V 12 ; FRT82B, tub-GAL80/FRT82B. Figure 8j ,l: y,w, ey-flp/+; act>y + >GAL4, UAS-GFP/ UAS-Ras V 12 ; FRT82B, tub-GAL80/FRT82B, lkb1 X 5 . Figure 8j ,m: y,w, ey-flp/+; act>y + >GAL4, UAS-GFP/UAS-Ras V 12 ; FRT82B, tub-GAL80/FRT82B, vps15 ird1−5 . Figure 8j ,n: y,w, ey-flp/+; act>y + >GAL4, UAS-GFP/ UAS-Ras V 12 ; FRT82B, tub-GAL80/FRT82B vps15 ird1−5 , lkb1 X 5 . Supplementary Fig. 1a ,b: hs-flp/+; FRT42, tub-GAL80/FRT42, vps34 m22 ; ubi-GFP/+. Supplementary Fig. 1c hs-flp/+; FRT42, tub-GAL80/FRT42, vps34 m22 ; act>y + >GAL4, UAS-GFP/+. Supplementary Fig. 1d : hs-flp/+; FRT42, tub-GAL80/FRT42, vps34 m22 ; act>y + >GAL4, UAS-GFP/UAS-vps34. Supplementary Fig. 1e: hs-flp; FRT82B, atg14 d5.2 /FRT82B, ubi-GFP. Supplementary  Fig. 2a,b: hs-flp/+; act>y + >GAL4, UAS-GFP/+; FRT82B, tub-GAL80/FRT82B, lkb1 X 5 . Supplementary Fig. 2c : ap-GAL4, UAS-GFP/+;+/UAS-lkb1 RNAi HMS01351 . Supplementary Fig. 2d : ap-GAL4/UAS-GFP::lkb1. Supplementary Fig. 2f : hs-flp/+; act>CD2>GAL4; UAS-GFPnls/UAS-crb RNAi JF02777 . Supplementary Fig. 2g : hs-flp/+; act>CD2>GAL4; UAS-GFPnls/UAS-lgl RNAi HMS01522 . Supplementary Fig. 2h : hsflp/+; FRT82B, atg14 d5.2 /FRT82B, ubi-GFP. Supplementary Fig. 2i ,j: y,w, hs-flp/+; act>y + >GAL4, UAS-GFP; FRT82B, tub-GAL80/FRT82B, vps15 ird1−5 , lkb1 X 5 . Supplementary Fig. 3a : ap-GAL4/+; UAS-vps15 RNAi /+. Supplementary Fig. 3b :
Drosophila genotypes listed by figures.
RNAi HMJ 30324 . Supplementary Fig. 3c : ap-GAL4/UAS-GFP::Rab5. Supplementary Fig.3d : ap-GAL4, UAS-vps34
RNAi HMJ 303247 /UAS-GFP::Rab5. Supplementary Fig. 3e : ap-GAL4/UAS-mCherry::ampkα; UAS-YFP::Rab7 /+. Supplementary Fig.3f : ap-GAL4/UAS-GFP::Rab7. Supplementary Fig. 3g ,h: ap-GAL4/UAS-GFP::Rab5
CA . Supplementary Fig. 6a : act-GAL4, UAS-GFP::dbFYVE/UASCh::wdfy2. Supplementary Cell culture. Caco-2 cells (from ATCC, tested monthly for mycoplasma and STR profiled annually) were routinely cultured in DMEM medium at 37 • C and 5% CO 2 supplemented with 15% FCS, 100 U ml −1 penicillin and 1 µg ml −1 streptomycin (Gibco). For siRNA transfection studies, 7 × 10 5 cells were seeded out one day prior to transfection. The siRNA was transfected using Lipofectamine RNAiMax transfection reagent (Invitrogen) according to the manufacturer's specifications; fresh medium was supplemented to the cells approximately 16 h post-transfection. The cells were typically analysed 72 h after transfection. For epithelial cyst formation experiments, siRNA-transfected cells were embedded in matrix rich in Matrigel and collagen as previously described for a period of five days 17 . The siRNAs used have the following sequences, Beclin-1 (5 -CUAAGGAGCUGCCGUUAUA-3 ), WDFY2 (5 -GCAUGUCUUUUAACCCGGA-3 ), SNX9 (5 -GUAACCGGAUCUAUGAUU A-3 ), SNX18 (5 -CAGGAUCGCUGUAACACUAUUUCUU-3 ), ALFY (5 -UAUU CGGCGGAGCAUUUCCUUUU-3 ), ATG14 (5 -GCAAAUCUUCGACGAUCCC AUAU-3 ), VPS34 (5 -ACUCAACACUGGCUAAUUAUU-3 ), LKB1 (Dharmacon L-005035-00-0020), Scrambled (5 -UAGCGACUAAACACAUCAA-3 ).
See Supplementary Fig. 7 for knockdown efficiencies. For 3-MA and SAR405 experiments, cells were seeded out 24 h prior to incubation with 100 mM 3-MA or 6 µM SAR405 for 4 h prior to harvesting for western blotting or continuously with daily media replacement over five days during organoid formation. 2D cultured Caco-2 cells were seeded out on coverslips 13 days to allow polarized cell monolayers to form, prior to transient transfections or immunolabelling. pcDNA3 vector containing Flag LKB1 (Addgene plasmid no. 8590) was transfected into confluent Caco-2 cells following the manufacturer's instructions (FuGENE6, Nerlien Meszansky).
Generation of stable cell lines. Stable cell lines were made using lentivirus generated pools. Third-generation lentivirus was generated using procedures and plasmids previously described 7 . Briefly, the GFP-and mCherry fusions were generated as Gateway pENTR-GFP and pENTR-mCherry plasmids by conventional restriction-enzyme-based cloning. From these vectors, lentiviral transfer vectors were generated by recombination into pLenti Destination vectors (Addgene plasmid number 17451, and vectors derived from pCDH-EF1α-MCS-IRES-PURO-or -BLAST(SystemBioSciences)) using Gateway LR reaction (Invitrogen). VSV-G pseudotyped lentiviral particles were packaged using a third-generation packaging system 38 (Addgene plasmid numbers 12251, 12253 and 12259). Cells were then transduced with virus and stable expressing populations were generated by antibiotic selection. Detailed cloning procedures can be requested from the authors. For co-culture experiments (GFP-tagged WDFY RA -expressing Caco-2 and Caco-2 cells), equal numbers of cells were mixed immediately prior to seeding on coverslips as stated above.
Time-lapse live-cell imaging. Long-term live-cell imaging was done on a DeltaVision wide-field fluorescence microscope (Applied Precision, GE Healthcare) using a 60× objective and 2 × 2 binning. Cells were seeded in Lab-Tek chambered coverglass (Nunc) and imaged in DMEM gfp -2 (Evrogen) supplemented with 15% FBS, 100 U ml −1 penicillin and 1 µg ml −1 streptomycin, 2 mM GlutaMAX and 25 mM HEPES. Cells were maintained at 37 • C and 5% CO 2 and 16 µm stacks were acquired comprising the whole volume of Caco-2 cell clusters. One stack per region was acquired before addition of SAR405 (end concentration 6 µM) or dimethylsulfoxide (DMSO). Then, time-lapse imaging was performed every 20 min for 8 h. Images were deconvolved and projected using the SoftWoRx software (Applied Precision, GE Healthcare) and processed in ImageJ for presentation. Short-term live-cell imaging was performed on a Deltavision OMX V4 microscope equipped with an Olympus 60× NA 1.42 objective, three cooled sCMOS cameras, a solid-state light source and a laser-based autofocus. Cells were seeded in Lab-Tek chambered coverglass (Nunc) and imaged in Live Cell Imaging buffer (Invitrogen) supplemented with 20 mM glucose. The environment was controlled with a heated stage and heated objective. Images were acquired simultaneously. Deconvolution and alignment were performed using softWoRx software.
Time-lapse images with GFP-tagged LKB1 and mCherry-tagged RAB5/RAB7/WDFY2 were recorded for 2 min every 5 s. Experiments with SAR405 treatment were imaged for 1 h every 2 min. Transferrin (10 µg ml −1 , Invitrogen, T23366) together with SAR405 was added for 15 min following 45 min incubation with SAR405. Subsequent replacement media also contained SAR405.
Correlative light and electron microscopy. Caco-2 cells stably expressing GFPtagged LKB1 and mCherry-tagged RAB7 were seeded on 3 mm sapphire discs (Engineering Office M. Wohlwend GmbH) and cultured for 72 h. Samples were high-pressure frozen using a Leica HPM100, and freeze substitution was performed as follows: sample carriers designed for sapphire discs were filled with 4 ml of freeze substituent (0.1% (w/v) uranyl acetate in acetone, 1% H 2 O) and placed in a temperature-controlling AFS2 (Leica) equipped with an FPS robot. Freeze substitution occurred at −90 • C for 48 h before the temperature was raised to −45 • C over a time span of 9 h. The samples were kept in the freeze substituent at −45 • C for 5 h before washing three times with acetone followed by a temperature increase (5 • C per hour) to −35 • C, and then infiltrated with increasing concentrations of Lowicryl K4 (10%, 25%, 75%, 4 h each). During the last two steps, the temperature was gradually increased to −25 • C before infiltrating three times with 100% Lowicryl (10 h each). Subsequent ultraviolet-polymerization was initiated for 48 h at −25 • C, and the temperature was then evenly increased to +20 • C (5 • C per hour). Polymerization then continued for another 24 h at 20 • C. Serial sections (∼110 nm) were cut on an Ultracut UCT ultramicrotome (Leica) and collected on 200-mesh carbon-coated grids. Samples were immediately placed in a droplet of 0.01 M NaOH, pH 12, in a glass-bottom Mattek dish and observed with a DeltaVision OMX microscope (Applied Precision, GE Healthcare) using a 60× objective, and 2 × 2 binning in wide-field fluorescence imaging mode. After recording the respective fluorescent GFP-and mCherry-signals, the grid was thoroughly washed in water before commencing with electron microscopy. The position of the fluorescent signal relative to the asymmetric centre of the carbon coated grid was later used to find the same position in the electron microscope. Sections were observed at 80 kV in a JEOL-JEM 1230 electron microscope and images were recorded using iTEM software with a Morada camera (Olympus). Cytosolic background fluorescence of mCherry::RAB7 was used to align the fluorescent image with the electron micrograph. The overlay of the fluorescent image with the electron micrograph was performed with Photoshop CS4.
Immunohistochemistry and microscopy. The ovaries of young adult females were removed, partly dissected and fixed in 4% formaldehyde/PBS (Polysciences no. 18814 ultrapure) for 30 min, and labelled immediately afterwards following standard protocols (PBS-Tween containing 0.5% BSA). Further dissection was performed when mounting, typically in Vectashield H-1000 (Vector labs) unless otherwise stated. The wing discs of wandering-stage third-instar larvae were dissected and fixed as above. Tissues were counterstained with Hoechst 33342 (Sigma-Aldrich) prior to mounting. Each experiment was performed at least three times and representative images were chosen from at least ten confocal scans of independent clones.
Line-intensity measurements were performed using ImageJ. Briefly, a line, or narrow box, from which the signal intensity was to be measured using the plot profile option, was placed spanning a region of interest, for example, from the dorsal to the ventral side of the wing. This automatically generated graphs, presented in the figures.
Cells grown on coverslips were fixed in 3% paraformaldehyde for 15 min and washed twice in PBS containing 0.05% saponin. The cells were then labelled using the indicated primary antibodies for 1 h, washed three times in PBS/saponin, labelled with secondary antibodies for 1 h, and washed twice in PBS/saponin followed by a PBS and water rinse before mounting in Mowiol containing Hoechst (Sigma). For visualization of 3D cultured cysts, cells were washed three times with PBS and fixed with 3% paraformaldehyde for 1 h at room temperature. Antibodies were incubated overnight in 3% BSA in PBS, counterstained with Hoechst, followed by a postfixation step of 30 min in 3% paraformaldehyde at room temperature. Samples were mounted in Vectashield H-1000. Confocal images were acquired on a Zeiss LSM 510, 710 or 780 confocal laser-scanning microscope. At least ten images were captured for each representative image depicted in the figures. Confocal stack handling and Image analysis was performed using ImageJ.
For structured illumination microscopy, GFP::Rab5 CA -expressing wing discs were fixed as above, labelled as above and mounted in ProLong Gold Antifade Reagent (Life Technologies). Three-dimensional structured illumination microscopy imaging was performed with the OMX V4 system (DeltaVision OMX Microscope Applied Precision, GE Healthcare). Discs were illuminated with a grid pattern and for each image plane, 15 images were collected (five phases for three rotations of the illumination pattern). z-stacks were acquired with a z-spacing of 125 nm. Super-resolution images were reconstructed from the raw image files, aligned and projected using Softworx software (Applied Precision, GE Healthcare).
Primary anti-sera included rabbit anti-GFP (Invitrogen no. A-11122, 1:300), goat anti-mCherry antibody (Acris Antibodies GmbH no. AP32117PU-S), rabbit anti-SNX18 (HPA037800, 1:500) from Atlas Antibodies, rabbit anti-aPKC (PKCζ no. sc-216, 1:500), rabbit p-AMPK (no. 2535, 1:100), anti-FLAG (no. ET-DY100, 1:400), rabbit anti-LKB1 (no. 3050, 1:5,000), rabbit anti-ATG14 (no. 5504, 1:500), rabbit anti-Beclin-1 (no. 3495, 1:1,000), rabbit anti-VPS34 (no. 4263, 1:1,000) were from Cell Signaling, rabbit anti-SNX3 (10772-1-AP, 1:500) from ProteinTech, mouse antialpha-tubulin (no. T5168, 1:20,000), mouse anti-beta-actin (no. 5316, 1:10,000) were from Sigma, mouse anti-GAPDH (ab9484, Immunoprecipitation and western blotting. mCherry-expressing cells, mCherry-tagged WDFY2-expressing cells and GFP-tagged LKB1 cells were immunoprecipitated as described previously 41 and were incubated with GFP trap beads overnight prior to elution. Experiments performed three times. Standard western blotting protocols were followed. Cell extracts were separated by SDS-PAGE on TGX Precast gels (Bio-Rad) and transferred to PVDF membranes (Merck Millipore). After the incubation with primary antibodies, immunodetection was performed by either fluorescently labelled or HRP-coupled secondary antibodies, and these were detected using either the Odyssey laser scanner (LI-COR) or Clarity Western ECL substrate solutions (Bio-Rad) with a ChemiDoc XRS+ imaging system (Bio-Rad), and analysed using ImageJ. The number of independent samples is given in quantifications and representative blots were chosen from at least three separate experiments.
GST pulldown assays. GST-fusion proteins were expressed in Escherichia coli BL21 (DE3) and/or SoluBL21 (Amsbio). After pulldown assays, the proteins were eluted from washed beads by boiling for 10 min in SDS-PAGE gel loading buffer. The proteins were separated by SDS-PAGE and transferred to PVDF membranes using the Trans-Blot Turbo Transfer System (Bio-Rad) and the radiolabelled proteins were detected in a PharosFX and PharosFX Plus Imager (Bio-Rad).
Statistics and reproducibility. All data sets presented in this paper derive from at least three independent experiments. When comparing identical cell lines following pharmacological treatments, paired two-tailed t-testing was performed using Microsoft Excel. When comparing cell lines expressing different DOI: 10.1038/ncb3631 transgenes or following knockdown of different genes, unpaired two-tailed t-testing was performed using Microsoft Excel. To determine whether the lumen phenotype distributions following pharmacological or knockdown treatments were significantly different from controls, chi-squared testing was performed using an online resource (http://www.socscistatistics.com). Two-way ANOVA was performed in Graphpad Prism 5 to assess differences between pupation rates. No statistical methods were used to predetermine sample size. All experiments including western blots and imaging experiments were performed at least three times with high reproducibility between independent experiments. Data availability. All data supporting the findings of this study are available from the corresponding authors on reasonable request. Supplementary Figure 6 Endosomal, physical and genetic interaction of Lkb1 and WDFY2. a, Follicular epithelial cells of developing egg chambers expressing GFP-tagged 2XFYVE (PI3P binding probe) and mCherry-tagged WDFY2. Arrowheads indicate some of the double positive punctae. Scale bar, 10mm. b, Caco-2 cells stable expressing GFP-tagged WDFY2 and mCherry-tagged LKB1 labelled with phalloidin 647 (Actin). Scale bar, 10mm. c, Caco-2 cells stably expressing GFP-tagged WDFY2 RA and mCherry-tagged LKB1. Scale bar, 10mm. d, Caco-2 cells stably expressing GFP-tagged LKB1 and mCherry-tagged WDFY2 were imaged over time and double positive punctae were tracked and traced (right panel). Arrowheads indicate start and stop points of individual punctae. Scale bar, 5mm. e, In vitro pull-down experiments using Drosophila and human proteins, where 35 S-labelled LKB1 was produced in the rabbit reticulocyte lysate and GSTtagged WDFY2 (or WDFY2 RA ) was produced in bacteria. f, Wild type, WDFY2 and WDFY2 RA expressing Caco-2 cells were either control or SAR405 treated for 4 hours prior to lysis and western blotting for p-AMPK and AMPK. From image intensity analysis the ratio of p-AMPK to AMPK was determined and average values from n, number of samples, were plotted, normalising control samples to 1; n values are indicated in the graph. Standard deviation error bars are shown. P-values were determined by paired two-tailed Student's t-test. n.s., non-significant difference. g, Caco-2 cells cultured in matrigel and treated with siRNA were labelled as indicated. Scale bar, 10mm. Experiments were performed 3 times, unless indicated otherwise, with similar results. Life Sciences Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form is intended for publication with all accepted life science papers and provides structure for consistency and transparency in reporting. Every life science submission will use this form; some list items might not apply to an individual manuscript, but all fields must be completed for clarity.
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Experimental design
Sample size
Describe how sample size was determined. Sample sizes were not predetermined by statistical methods.
Data exclusions
Describe any data exclusions.
No data was excluded from analysis.
Replication
Describe whether the experimental findings were reliably reproduced.
Occassionally 3d cyst assay positive control did not form cysts and entire experiment was discarded. This is attributable to known batch differences with matrigel.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Samples were not randomized for the experiments
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Blinding was not used for the experiments
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
